These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18780336)

  • 21. Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect.
    Kim EJ; Kim SO; Lee DH; Lim H; Lee MG
    Biopharm Drug Dispos; 2001 Apr; 22(3):119-28. PubMed ID: 11745914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic and gastrointestinal first-pass effects of vitexin-4″-O-glucoside in rats.
    Chen Y; Zhang W; Li D; Ai J; Meng Y; Ying X; Kang T
    J Pharm Pharmacol; 2013 Oct; 65(10):1500-7. PubMed ID: 24028617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of L-FMAUS, a new antiviral agent, after intravenous and oral administration to rats: contribution of gastrointestinal first-pass effect to low bioavailability.
    Chung HJ; Lee JH; Woo SJ; Park HK; Koo CH; Lee MG
    Biopharm Drug Dispos; 2007 May; 28(4):187-97. PubMed ID: 17377948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic and intestinal first-pass effects of a new hepatoprotective agent, YH439, in rats.
    Kim J; Han KS; Lee JW; Lee MG
    Res Commun Mol Pathol Pharmacol; 1998 Nov; 102(2):125-36. PubMed ID: 10100504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent pharmacokinetics and first-pass effects of mirodenafil, a new erectogenic, in rats.
    Choi YH; Lee YS; Bae SH; Kim TK; Lee BY; Lee MG
    Biopharm Drug Dispos; 2009 Sep; 30(6):305-17. PubMed ID: 19639551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal first-pass effect of YJA-20379-8, a new reversible proton pump inhibitor, in rats.
    Kim J; Kim EJ; Han KS; Chang MS; Lee MG
    J Pharm Pharmacol; 1999 Sep; 51(9):1031-6. PubMed ID: 10528986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral bioavailability and intestinal secretion of amitriptyline: Role of P-glycoprotein?
    Abaut AY; Chevanne F; Le Corre P
    Int J Pharm; 2007 Feb; 330(1-2):121-8. PubMed ID: 17092666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism.
    Lau YY; Okochi H; Huang Y; Benet LZ
    Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-pass metabolism of 5-fluorouracil in rats.
    Yuasa H; Gu J; Hayashi Y; Watanabe J
    J Pharm Pharmacol; 1998 Sep; 50(9):1019-25. PubMed ID: 9811163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and first-pass metabolism of astaxanthin in rats.
    Choi HD; Kang HE; Yang SH; Lee MG; Shin WG
    Br J Nutr; 2011 Jan; 105(2):220-7. PubMed ID: 20819240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics.
    Wong SL; Cavanaugh J; Shi H; Awni WM; Granneman GR
    Clin Pharmacol Ther; 1996 Jul; 60(1):48-53. PubMed ID: 8689811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of isoliquiritigenin and its metabolites in rats: low bioavailability is primarily due to the hepatic and intestinal metabolism.
    Lee YK; Chin YW; Bae JK; Seo JS; Choi YH
    Planta Med; 2013 Nov; 79(17):1656-65. PubMed ID: 24108436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect.
    Shin JH; Choi KY; Kim YC; Lee MG
    Antimicrob Agents Chemother; 2004 May; 48(5):1756-62. PubMed ID: 15105131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymmetric intestinal first-pass metabolism causes minimal oral bioavailability of midazolam in cynomolgus monkey.
    Nishimura T; Amano N; Kubo Y; Ono M; Kato Y; Fujita H; Kimura Y; Tsuji A
    Drug Metab Dispos; 2007 Aug; 35(8):1275-84. PubMed ID: 17470527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats.
    Chung HJ; Choi YH; Choi HD; Jang JM; Shim HJ; Yoo M; Kwon JW; Lee MG
    Eur J Pharm Sci; 2006 Mar; 27(4):363-74. PubMed ID: 16387482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single oral dose pharmacokinetics of amitriptylinoxide and amitriptyline in humans.
    Kuss HJ; Jungkunz G; Johannes KJ
    Pharmacopsychiatry; 1985 Jul; 18(4):259-62. PubMed ID: 4023050
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The demethylation of amitriptyline administered by oral and intramuscular routes.
    Burch JE; Herries DG
    Psychopharmacology (Berl); 1983; 80(3):249-53. PubMed ID: 6412269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-independent pharmacokinetics of torasemide after intravenous and oral administration to rats.
    Lee DY; Kim JY; Kim YC; Kwon JW; Kim WB; Lee MG
    Biopharm Drug Dispos; 2005 Jul; 26(5):173-82. PubMed ID: 15841492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of intestinal availability of various drugs in the oral absorption process using portal vein-cannulated rats.
    Matsuda Y; Konno Y; Satsukawa M; Kobayashi T; Takimoto Y; Morisaki K; Yamashita S
    Drug Metab Dispos; 2012 Dec; 40(12):2231-8. PubMed ID: 22930277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.